在结石疾病的预防性药理疗法中对特定类别的副作用进行比较
Ryan S Hsi1, Joseph J Crivelli2, Phyllis L Yan3
1Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Urology practice
|December 20, 2023
概括
与酸相比,用于预防结石的 thiazides 和 allopurinol 与更高的高血糖/糖尿病率有关. 对服用这些结石药物的患者来说,对代谢副作用的监测至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 临床指导方针提倡在接受结石疾病预防性药物治疗的患者中监测代谢障碍.
- 了解常见预防药物的比较副作用概况对于患者安全和治疗优化至关重要.
研究的目的:
- 为了比较服用酸, thiazides 或 allopurinol 预防结石的患者中不良事件的发生频率.
- 评估不同药理疗法与特定代谢障碍之间的关联.
主要方法:
- 一项回顾性队列研究,利用2008年至2019年期间被诊断患有结石疾病的劳动年龄成人索赔数据.
- 确定了新处方酸盐, thiazides 或 allopurinol 的患者,并使用多变量逻辑回归分析了他们的 2 年不良结果发生率,并对共变量进行了调整.
主要成果:
- 与酸盐和氨醇相比, thiazides 与高血症,低血糖症和高血糖症/糖尿病的最高未调整率有关.
- 调整后的分析显示,与酸相比, thiazides 增加了低血糖和高血糖/糖尿病的几率,而 allopurinol 增加了高血糖/糖尿病的几率.
结论:
- 这些发现支持现有的临床指南,建议定期进行血清检测,以监测预防性药理疗法对结石的不良影响.
- 对药物副作用的比较分析有助于明智的临床决策和患者管理策略.
相关概念视频
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
236
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
236
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
573
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
573
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
659
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
659
01:25Antihypertensive Drugs: Direct Renin Inhibitors
632
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
632
01:28Renal Drug Excretion: Tubular Secretion
190
Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
190